Milan, Italy, June 3, 2025 – Approxima Srl announced today the appointment of Rick Geoffrion, seasoned MedTech entrepreneur as an independent Board Director.
Rick Geoffrion has more than 35 years of management experience in the medical device industry and more specifically in the cardiovascular device space. Mr. Geoffrion has previously led the company foundation for four medical device companies: Mitralign (acquired by Edwards), CircuLite (acquired by HeartWare), FlowMedica (acquired by Angiodynamics) and X-Cell and guided the recapitalization and redirection of two other successful medical device companies: Impella (acquired by Abiomed) and Pathway (acquired by Bayer). Mr. Geoffrion has served as the Chairman of Impella CardioSystems, Circulite, FlowMedica, Aventamed (acquired by Storz) and Corflow Therapeutics. .
Rick currently serves as the President and CEO of Cyrano Therapeutics, Vice Chairman of the Mullings Group and as a member of the Executive Committee and Board of Directors of the Medical Device Innovation Consortium..
Mr. Geoffrion joins Approxima at a pivotal moment, following the successful first closing of the company’s Series A financing round (read more: LINK) and as it prepares to initiate pilot clinical trials of its percutaneous right ventricular reshaping technology for the treatment of tricuspid regurgitation.
